SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019872
Filing Date
2022-05-12
Accepted
2022-05-12 16:17:47
Documents
45
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20220331.htm   iXBRL 10-Q 991411
2 EX-31.1 mnov-ex311_9.htm EX-31.1 10996
3 EX-31.2 mnov-ex312_8.htm EX-31.2 11008
4 EX-32.1 mnov-ex321_6.htm EX-32.1 7895
5 EX-32.2 mnov-ex322_7.htm EX-32.2 7883
  Complete submission text file 0001564590-22-019872.txt   3617216

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnov-20220331.xsd EX-101.SCH 28308
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20220331_cal.xml EX-101.CAL 31794
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20220331_def.xml EX-101.DEF 75389
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20220331_lab.xml EX-101.LAB 248669
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20220331_pre.xml EX-101.PRE 178041
39 EXTRACTED XBRL INSTANCE DOCUMENT mnov-10q_20220331_htm.xml XML 474918
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 22918050
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences